EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peroxiredoxin 2 Is a Potential Objective Indicator for Severity and the Clinical Status of Subarachnoid Hemorrhage Patients

Zheng Peng iD, Cong Pang iD, Xiao-Jian Li iD, Hua-Sheng Zhang, Jia-Tong Zhang, Qi Zhu iD, Hua-Jie Xu, Yong-Yue Gao, Zong Zhuang iD, Wei Li iD, Qing-Rong Zhang iD, Yue Lu iD und 1 weitere

Disease Markers · 2023

DOI: 10.1155/2023/5781180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Markers, 2023. Verfasst von Zheng Peng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We have demonstrated that peroxiredoxin 2 (Prx2) released from lytic erythrocytes and damaged neurons into the subarachnoid space could activate microglia and then result in neuronal apoptosis. In this study, we tested the possibility of using Prx2 as an objective indicator for severity of the subarachnoid hemorrhage (SAH) and the clinical status of the patient. Materials and Methods. SAH patients were prospectively enrolled and followed up for 3 months. Cerebrospinal fluid (CSF) and blood samples were collected 0-3 and 5-7 days after SAH onset. The levels of Prx2 in the CSF and the blood were measured by an enzyme-linked immunosorbent assay (ELISA). We used Spearman’s rank coefficient to assess the correlation between Prx2 and the clinical scores. Receiver operating characteristic (ROC) curves were used for Prx2 levels to predict the outcome of SAH by calculating the area under the curve (AUC). Unpaired Student’s t -test was used to analyze the differences in continuous variables across cohorts.

Results

Prx2 levels in the CSF increased after onset while those in the blood decreased. Existing data showed that Prx2 levels within 3 days in the CSF after SAH were positively correlated with the Hunt-Hess score ( R = 0.761 , P < 0.001 ). Patients with CVS had higher levels of Prx2 in their CSF within 5-7 days after onset. Prx2 levels in the CSF within 5-7 days can be used as a predictor of prognosis. The ratio of Prx2 in the CSF and the blood within 3 days of onset was positively correlated with the Hunt-Hess score and negatively correlated with Glasgow Outcome Scale (GOS; R = ‐ 0.605 , P < 0.05 ).

Conclusion

We found that the levels of Prx2 in the CSF and the ratio of Prx2 in the CSF and the blood within 3 days of onset can be used as a biomarker to detect the severity of the disease and the clinical status of the patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subarachnoid HemorrhageHumansPeroxiredoxinsPrognosisBiomarkersApoptosis

Substanzen

PeroxiredoxinsBiomarkers

Autor:innen und Institutionen

  • Department of Neurosurgery, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China.
  • Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008 Jiangsu, China.

ORCID-Profile: Zheng Peng, Cong Pang, Xiao-Jian Li, Qi Zhu, Zong Zhuang, Wei Li, Qing-Rong Zhang, Yue Lu, Chun-Hua Hang

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Peng, Z., Pang, C., Li, X. J., Zhang, H. S., Zhang, J. T., Zhu, Q., Xu, H. J., Gao, Y. Y., Zhuang, Z., Li, W., Zhang, Q. R., Lu, Y., & Hang, C. H. (2023). Peroxiredoxin 2 Is a Potential Objective Indicator for Severity and the Clinical Status of Subarachnoid Hemorrhage Patients. Disease Markers. https://doi.org/10.1155/2023/5781180

Vancouver

Peng Z, Pang C, Li XJ, Zhang HS, Zhang JT, Zhu Q, et al. Peroxiredoxin 2 Is a Potential Objective Indicator for Severity and the Clinical Status of Subarachnoid Hemorrhage Patients. Disease Markers. 2023. doi:10.1155/2023/5781180

BibTeX
@article{Peng2023,
  author = {Peng, Zheng and Pang, Cong and Li, Xiao-Jian and Zhang, Hua-Sheng and Zhang, Jia-Tong and Zhu, Qi and Xu, Hua-Jie and Gao, Yong-Yue and Zhuang, Zong and Li, Wei and Zhang, Qing-Rong and Lu, Yue and Hang, Chun-Hua},
  title = {Peroxiredoxin 2 Is a Potential Objective Indicator for Severity and the Clinical Status of Subarachnoid Hemorrhage Patients},
  journal = {Disease Markers},
  year = {2023},
  doi = {10.1155/2023/5781180}
}
Kostenlos starten →